Sage Journals: Discover world-class research

Abstract

The potential for noninvasive monitoring and quantification of tumor angiogenesis with contrast-enhanced ultrasound imaging has been investigated in a murine cancer model. Seventy athymic nude mice were implanted with the human melanoma cell line DB-1 but only 30 of these were available for the final study. The 30 mice were divided into three groups (10 mice/group), which were studied with contrast-enhanced ultrasound imaging 4, 5 or 6 weeks post-implantation. Power Doppler and pulse inversion harmonic imaging (PIHI) were performed (in real time and intermittently) with a Sonoline Elegra scanner (Siemens Medical Solutions, Issaquah, WA) following injection of Optison (dose: 0.4–0.6 ml/kg; GE Healthcare, Princeton, NJ). Ultrasound results were compared to immunohistochemical stains for endothelial cells (CD31), vascular endothelial growth factor (VEGF) and cyclooxygenase-2 (COX-2). Linear regression analysis indicated statistically significant correlations between the percent area stained with VEGF and ultrasound measures of tumor neovascularity obtained with all three techniques (p < 0.01). Contrast-enhanced ultrasound imaging of tumor neovascularity appears to provide a noninvasive marker of angiogenesis corresponding to the expression of VEGF in the DB-1 model and may become a useful tool for monitoring clinical anti-angiogenic therapies.

Keywords

Angiogenesis contrast-enhanced ultrasound imaging melanoma murine xenograft model pulse inversion harmonic imaging

Get full access to this article

View all access options for this article.

References

Folkman

What is the evidence that tumors are angiogenesis dependent?

J Natl Cancer Inst 82, 4–6 (1990).

Holmgren

O'Reilly

Folkman

Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1, 149–153 (1995).

. Tumor angiogenesis: molecular pathology, therapeutic targeting, and imaging. Acad Radiol 7, 800–811 (2000).

McDonald

Choyke

. Imaging of angiogenesis: from microscope to clinic. Nat Med 9, 713–725 (2003).

Perini

Choe

Yodh

Non-invasive assessment of tumor neovasculature: techniques and clinical applications. Cancer Metastasis Rev 27, 615–630 (2008).

Folkman

Hahnfeldt

Hlatky

The Logic of Anti-Angiogenic Gene Therapy. Target Tissues and Target Diseases — Cancer (Cold Spring Harbor Laboratory Press, 1998).

Thomas

. Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 271, 603–606 (1996).

Risau

Mechanisms of angiogenesis. Nature, 386, 671–674 (1997).

Ferrara

Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Intl 56, 794–814 (1999).

10.

Bremnes

Camps

Sirera

Angiogenesis in non-small cell lung cancer: The prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood. Lung Cancer 51, 143–158 (2006).

11.

Denkert

Köbel

Berger

Expression of cyclooxygenase 2 in human malignant melanoma. Cancer Res 61, 303–308 (2001).

12.

Dempke

Rie

Grothey

Schmoll

. Cyclooxygenase-2: a novel target for cancer chemotherapy? J Cancer Res Clin Oncol 127, 411–417 (2001).

13.

. COX-2 inhibitors in cancer treatment and prevention, a recent development. Anti-Cancer Drugs 13, 127–137 (2002).

14.

Newman

. The biology of PECAM-1. J Clin Invest 99, 3–8 (1997).

15.

O'Brien

Gaoyuan

Makrigiannakis

De Lisser

. Role of immunoreceptor tyrosine-based inhibitory motifs of PECAM-1 in PECAM-1-dependent cell migration. Am J Physiol Cell Physiol 287, C1103–C1113 (2004).

16.

NIH/NCI. http://www.cancer.gov/clinicaltrials (accessed January 30^th, 2009).

17.

Ferrara

Merritt

CRB

Burns

Evaluation of tumor angiogenesis with US: imaging, Doppler and contrast agents. Acad Radiol 7, 824–839 (2000).

18.

Neeman

Gilad

Dafni

Cohen

Molecular imaging of angiogenesis. J Magn Reson Imaging 25, 1–12 (2007).

19.

Goldberg

Raichlen

Forsberg

Ultrasound Contrast Agents: Basic Principles and Clinical Applications, 2nd Ed. (Martin Dunitz Ltd., London, 2001).

20.

Forsberg

Potoczek

Assessment of angiogenesis: implications for ultrasound imaging. Ultrasonics 42, 325–330 (2004).

21.

Forsberg

Kuruvilla

Pascua

Comparing contrast-enhanced color flow imaging and pathological measures of breast lesion vascularity. Ultrasound Med Biol 34, 1365–137 (2008).

22.

Wahl

Owen

Burd

Regulation of intracellular pH in human melanoma: potential therapeutic implications. Mol Canc Ther 1, 617–628 (2002).

23.

Forsberg

Dicker

Thakur

Comparing contrast enhanced ultrasound to immunohistochemical markers of angiogenesis in a human melanoma xenograft model: preliminary results. Ultrasound Med Biol 28, 445–451, 2002.

24.

Shi

Forsberg

Ultrasonic characterization of the nonlinear properties of contrast microbubbles. Ultrasound Med. Biol 26, 93–104 (2000).

25.

Bell

Bamber

Eckersley

. Segmentation and analysis of colour Doppler images of tumour vasculature. Ultrasound Med Biol 21, 635–637 (1995).

26.

Chaudhari

Forsberg

Voodarla

Breast tumor vascularity identified by contrast enhanced ultrasound and pathology: initial results. Ultrasonics 38, 105–109 (2000).

27.

Fleicher

. Sonographic depiction of tumor vascularity and flow from in vivo models to clinical applications. J Ultrasound Med 19, 55–61 (2000).

28.

Schroeder

Hauff

Bartels

Tumor vascularization in experimental melanomas: correlation between unenhanced and contrast enhanced power Doppler imaging and histological grading. Ultrasound Med Biol 27, 761–771 (2001).

29.

Iordanescu

Becker

Zetter

Dunning

Taylor

. Tumor vascularity: evaluation in a murine model with contrast-enhanced color Doppler US—effect of angiogenesis inhibitors. Radiology, 222, 460–467 (2002).

30.

Krix

Kiessling

Vosseler

Comparison of intermittent-bolus contrast imaging with conventional power Doppler sonography: quantification of tumor perfusion in small animals. Ultrasound Med Biol 29, 1093–1103 (2003).

31.

Forsberg

Liu

Contrast enhanced US for monitoring the effect of VEGF Trap on melanoma tumor vascularity, in Proc IEEE Ultrason Symp, pp. 1977–1980 (2007).

32.

Niermann

Fleischer

Huamani

Measuring tumor perfusion in control and treated murine tumors: correlation of microbubble contrast-enhanced sonography to dynamic contrast-enhanced magnetic resonance imaging and fluorodeoxyglucose positron emission tomography. J Ultrasound Med 26, 749–756 (2007).

33.

Pollard

Broumas

Wisner

Vekich

Ferrara

. Quantitative contrast enhanced ultrasound and CT assessment of tumor response to antiangiogenic therapy in rats. Ultrasound Med Biol 33, 235–245 (2007).

34.

Jain

. Barriers to drug delivery in solid tumors. Sci Am 271, 58–65 (1994).

Monitoring Angiogenesis in Human Melanoma Xenograft Model Using Contrast-Enhanced Ultrasound Imaging

Abstract

Keywords

Get full access to this article

References